Search Results

Agricola

Record details

Exosomal miR-4516 derived from ovarian cancer stem cells enhanced cisplatin tolerance in ovarian cancer by inhibiting GAS7.

• Authors : Pan X; Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215000, China.; Shi X

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics ; MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism

• Source: Gene [Gene] 2024 Nov 15; Vol. 927, pp. 148738. Date of Electronic Publication: 2024 Jun 30.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

Tanshinone T1/T2A inhibits non-small cell lung cancer through Lin28B-let-7-BORA/MYC regulatory network.

• Authors : Li Y; Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai, China.; Guo Z

Subjects: Abietanes*/Abietanes*/Abietanes*/pharmacology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

• Source: Gene [Gene] 2025 Jan 30; Vol. 935, pp. 149058. Date of Electronic Publication: 2024 Oct 29.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

RFWD2 increases proliferation and CDDP resistance of osteosarcoma cells.

• Authors : Liu P; Department of Health Management Center, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, China.; Xie N

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/genetics ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/drug therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/pathology

• Source: Gene [Gene] 2025 Jan 15; Vol. 933, pp. 148973. Date of Electronic Publication: 2024 Sep 28.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

A novel cancer-germline gene DAZL promotes progression and cisplatin resistance of non-small cell lung cancer by upregulating JAK2 and MCM8.

• Authors : Zhou L; Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Hunan Normal University, Changsha 41007, Hunan, China; College of Clinical Laboratory, Changsha Medical University, Changsha, Hunan, China

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/pathology

• Source: Gene [Gene] 2024 Jul 20; Vol. 916, pp. 148449. Date of Electronic Publication: 2024 Apr 06.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).

• Authors : Maleki N; Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Islamic Azad University-Tehran North Branch, Tehran, Iran.; Yavari N

Subjects: Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/Antineoplastic Agents, Phytogenic/*administration & dosage ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism

• Source: Gene [Gene] 2022 May 20; Vol. 823, pp. 146275. Date of Electronic Publication: 2022 Feb 18.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.

• Authors : Wang Z; Department of Obstetrics and Gynecology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China. Electronic address: .; Li F

Subjects: Cisplatin/Cisplatin/Cisplatin/*pharmacology ; Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/Drug Resistance, Neoplasm/*drug effects ; Period Circadian Proteins/Period Circadian Proteins/Period Circadian Proteins/*genetics

• Source: Gene [Gene] 2022 Jan 30; Vol. 809, pp. 146003. Date of Electronic Publication: 2021 Oct 11.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

Nano-realgar suppresses lung cancer stem cell growth by repressing metabolic reprogramming.

• Authors : Yang FR; College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People's Republic of China. Electronic address: .; Zhao YF

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage ; Arsenicals/Arsenicals/Arsenicals/*administration & dosage ; Glucose/Glucose/Glucose/*metabolism

• Source: Gene [Gene] 2021 Jul 01; Vol. 788, pp. 145666. Date of Electronic Publication: 2021 Apr 19.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

Clinical significance of LARGE1 in progression of liver cancer and the underlying mechanism.

• Authors : Wang M; Medical Research & Laboratory Diagnostic Center, Central Hospital affiliated to Shandong First Medical University, Jinan 250013, China.; Tao H

Subjects: Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*genetics ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*pathology ; N-Acetylglucosaminyltransferases/N-Acetylglucosaminyltransferases/N-Acetylglucosaminyltransferases/*genetics

• Source: Gene [Gene] 2021 May 05; Vol. 779, pp. 145493. Date of Electronic Publication: 2021 Feb 13.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details

The ATPase subunit of ATP6V1C1 inhibits autophagy and enhances radiotherapy resistance in esophageal squamous cell carcinoma.

• Authors : Yao X; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; Center of Interventional Radiology and Vascular surgery, Department of Radiology, Zhongda hospital, Southeast university, Nanjing 210009, China.

Subjects: Autophagy/Autophagy/Autophagy/*genetics ; Esophageal Neoplasms/Esophageal Neoplasms/Esophageal Neoplasms/*genetics ; Esophageal Squamous Cell Carcinoma/Esophageal Squamous Cell Carcinoma/Esophageal Squamous Cell Carcinoma/*genetics

• Source: Gene [Gene] 2021 Feb 05; Vol. 768, pp. 145261. Date of Electronic Publication: 2020 Oct 22.Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic

Record details